These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4049312)

  • 21. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease].
    Liu H; Chen Z; Gao R
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):595-8. PubMed ID: 8697924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
    Gurbel PA; Bliden KP; Tantry US
    J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers.
    Dharmasaroja PA; Sae-Lim S
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):649-52. PubMed ID: 20689403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
    Maree AO; Curtin RJ; Dooley M; Conroy RM; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2005 Oct; 46(7):1258-63. PubMed ID: 16198840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
    de Gaetano G; Cerletti C; Dejana E; Latini R
    Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
    Schiff M; Hochberg MC; Oldenhof J; Brune K
    Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
    Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
    Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombocyte function of healthy probands taking 50 mg of acetylsalicylic acid per day].
    Sinzinger H; Kritz H; Pirich C; Karanikas G; Kurtaran A; Banyai M; Peskar BA; Rehak P
    Wien Klin Wochenschr; 1995; 107(15):457-63. PubMed ID: 7676685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
    Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid.
    Rosenkranz B; Frölich JC
    Prostaglandins Leukot Med; 1985 Sep; 19(3):289-300. PubMed ID: 3864170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
    Franchi F; Schneider DJ; Prats J; Fan W; Rollini F; Been L; Taatjes-Sommer HS; Bhatt DL; Deliargyris EN; Angiolillo DJ
    J Thromb Thrombolysis; 2022 Oct; 54(3):373-381. PubMed ID: 36036856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of acetylsalicylic acid in 3 different formulations on in vitro and in vivo platelet function tests. An experimental study on healthy male volunteers.
    Kutti J; Safai-Kutti S; Sigvaldason A; Edgar B; Lundborg P
    Scand J Haematol; 1984 Apr; 32(4):379-84. PubMed ID: 6719042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.